Establishment and phenotypic characterization of a rat model with a clinically relevant phenotype for chronic gouty arthritis

Background: The study of chronic gouty arthritis (CGA) is limited by the absence of animal models that faithfully mimic its chronic progression. Existing models fail to capture the transition from acute flares to chronic joint damage, highlighting the need for a more representative model. Methods: A novel CGA model was established in SD rats using a combined strategy. Chronic hyperuricemia was induced via a diet containing 2% potassium oxonate and 12% yeast. This was supplemented with twice-weekly gavage of hypoxanthine to simulate acute uric acid fluctuations, followed by intra-articular injections of monosodium urate (MSU) crystals into the ankle and plantar region. This protocol lasted 10 weeks. Rats were divided into control, model, and allopurinol treatment groups. Evaluations included serum uric acid monitoring, joint swelling and inflammation scores, hindlimb hanging tests, histopathology, micro-CT, and inflammatory cytokine assays. Results: The model group exhibited sustained hyperuricemia with acute fluctuations, persistent joint swelling, significantly elevated inflammation scores (P<0.0001), and reduced hanging time (P<0.0001), indicating chronic pain and functional impairment. Histology revealed synovial hyperplasia, inflammatory cell infiltration, and cartilage damage. Micro-CT confirmed significant bone erosion, evidenced by an increased bone surface/bone volume ratio (P<0.001). Serum levels of IL-1β, TNF-α, and IL-6 were significantly elevated. Allopurinol treatment effectively lowered uric acid and alleviated joint swelling and bone erosion. Conclusion: This study successfully established and systematically characterized the phenotypic features of a CGA rat model that integrates chronic hyperuricemia, acute uric acid fluctuations, and local MSU crystal deposition. Phenotypically, this model recapitulates the core features of human CGA, including joint swelling, bone erosion, and functional impairment, thereby providing an experimental platform for investigating chronic joint damage induced by multiple interacting factors.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-04-17
DOI
https://doi.org/10.3389/fimmu.2026.1752151
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Establishment and phenotypic characterization of a rat model with a clinically relevant phenotype for chronic gouty arthritis

Yidi Huang, Luming Zhao, Jinying Fang, Cunxiang Xie et al.
Frontiers in Immunology
Gout, Hyperuricemia, Uric Acid
article

Establishment and phenotypic characterization of a rat model with a clinically relevant phenotype for chronic gouty arthritis

Yidi Huang, Luming Zhao, Jinying Fang, Cunxiang Xie, Hao Wang, Kaiyuan Yang, Hailong Wang, Yingkai Gao, Mingxuan Liu
article en

Abstract

Background: The study of chronic gouty arthritis (CGA) is limited by the absence of animal models that faithfully mimic its chronic progression. Existing models fail to capture the transition from acute flares to chronic joint damage, highlighting the need for a more representative model. Methods: A novel CGA model was established in SD rats using a combined strategy. Chronic hyperuricemia was induced via a diet containing 2% potassium oxonate and 12% yeast. This was supplemented with twice-weekly gavage of hypoxanthine to simulate acute uric acid fluctuations, followed by intra-articular injections of monosodium urate (MSU) crystals into the ankle and plantar region. This protocol lasted 10 weeks. Rats were divided into control, model, and allopurinol treatment groups. Evaluations included serum uric acid monitoring, joint swelling and inflammation scores, hindlimb hanging tests, histopathology, micro-CT, and inflammatory cytokine assays. Results: The model group exhibited sustained hyperuricemia with acute fluctuations, persistent joint swelling, significantly elevated inflammation scores (P<0.0001), and reduced hanging time (P<0.0001), indicating chronic pain and functional impairment. Histology revealed synovial hyperplasia, inflammatory cell infiltration, and cartilage damage. Micro-CT confirmed significant bone erosion, evidenced by an increased bone surface/bone volume ratio (P<0.001). Serum levels of IL-1β, TNF-α, and IL-6 were significantly elevated. Allopurinol treatment effectively lowered uric acid and alleviated joint swelling and bone erosion. Conclusion: This study successfully established and systematically characterized the phenotypic features of a CGA rat model that integrates chronic hyperuricemia, acute uric acid fluctuations, and local MSU crystal deposition. Phenotypically, this model recapitulates the core features of human CGA, including joint swelling, bone erosion, and functional impairment, thereby providing an experimental platform for investigating chronic joint damage induced by multiple interacting factors.

Frontiers in ImmunologyVol. 17
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Openalex Percentile: Top 21%
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.